{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:21Z","timestamp":1791414141854,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Merck & Co"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.anaerobe.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T16:26:11Z","timestamp":1475857571000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The underappreciated in\u00a0vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems"],"prefix":"10.1016","volume":"43","author":[{"given":"Ellie J.C.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Citron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerin L.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa S.","family":"Leoncio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Vreni","family":"Merriam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2016.09.008_bib1","author":"U.S"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib3","unstructured":"American Diabetes Association. Statistics about diabetes. a. www.diabetes.org\/diabetes-basics\/statistics. accessed 7-9-16."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib5","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JCM.00551-07","article-title":"Bacteriology of moderate to severe diabetic foot infections and in\u00a0vitro activity of antimicrobial agents","volume":"45","author":"Citron","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib7","first-page":"325","article-title":"Chapter 6 resistance in anaerobic bacteria","volume":"vol. 316","author":"Goldstein","year":"2008"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib8","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1128\/AAC.00046-15","article-title":"Risk factors for resistance to \u03b2-Lactam\/\u03b2-lactamase inhibitors and ertapenem in Bacteroides bacteremia","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.anaerobe.2011.02.007","article-title":"Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan","volume":"17","author":"Sherwood","year":"2011","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib10","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1086\/428623","article-title":"Anaerobic sepsis due to multi-resistant Bacteroides fragilis: cure and clinical response with linezolid therapy","volume":"40","author":"Wareham","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2011.12.022","article-title":"Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF","volume":"18","author":"Trevi\u00f1o","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0924-8579(03)00087-6","article-title":"Activity of linezolid against anaerobic bacteria","volume":"22","author":"Behra-Miellet","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"Suppl.\u00a0S2","key":"10.1016\/j.anaerobe.2016.09.008_bib13","first-page":"S9","article-title":"Linezolid in\u00a0vitro: mechanism and antimicrobial spectrum","volume":"51","author":"Livermore","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib14","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/AAC.47.7.2334-2338.2003","article-title":"In\u00a0vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria","volume":"47","author":"Citron","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib15","series-title":"Wadsworth-KTL Anaerobic Bacteriology Manual","author":"Jousimies-Somer","year":"2002"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib16","volume":"vol. 2","author":"Versalovic","year":"2011"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib17","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard\u2014 Eighth Edition. CLSI Document M11-a8","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib18","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; 26th Informational Supplement. CLSI Document. M100-s26","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.anaerobe.2016.09.008_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin structure infections (ESTABLISH-2): a randomized, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Inf. Dis."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"J.\u00a0Am. Med. Assoc."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.anaerobe.2016.09.008_bib21","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cit617","article-title":"Tedizolid for the management of acute bacterial skin and skin structure infections: efficacy summary","volume":"58","author":"O'Riordan","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In\u00a0vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib23","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1128\/AAC.00228-09","article-title":"In\u00a0vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent","volume":"53","author":"Schaadt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.09.008_bib24","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00355-08","article-title":"Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems","volume":"52","author":"Liu","year":"2008","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996416301172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996416301172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T10:50:45Z","timestamp":1568458245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996416301172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":24,"alternative-id":["S1075996416301172"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2016.09.008","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The underappreciated in\u00a0vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}